Twin Peaks Wealth Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Twin Peaks Wealth Advisors's AZN Position: Q2 2026 in Review
Twin Peaks Wealth Advisors increased its AstraZeneca (AZN) stake by 37% in Q2 2026, buying an estimated $62.4K and bringing the position to 1,228 shares worth $233K. The position accounts for 0.05% of the portfolio, ranked #196.
Twin Peaks Wealth Advisors first reported a position in AZN in Q2 2025 and has held it in 4 quarters since. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Twin Peaks Wealth Advisors held 1,228 shares of AstraZeneca worth $233K as of Q2 2026.
- Twin Peaks Wealth Advisors bought 332 AstraZeneca shares in Q2 2026, an estimated $62.4K.
- AstraZeneca made up 0.05% of Twin Peaks Wealth Advisors's portfolio in Q2 2026, its #196 holding.
- Twin Peaks Wealth Advisors first reported a position in AstraZeneca in Q2 2025 and has held it in 4 quarters since.
- 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.